The Skin Histopathology of Pro- and Parabiotics in a Mouse Model of Atopic Dermatitis

被引:1
|
作者
Kim, Hun Hwan [1 ]
Jeong, Se Hyo [1 ]
Park, Min Yeong [1 ]
Bhosale, Pritam Bhagwan [1 ]
Abusaliya, Abuyaseer [1 ]
Heo, Jeong Doo [2 ]
Kim, Hyun Wook [3 ]
Seong, Je Kyung [4 ]
Kim, Tae Yang [5 ]
Park, Jeong Woo [5 ]
Kim, Byeong Soo [5 ]
Kim, Gon Sup [1 ]
机构
[1] Gyeongsang Natl Univ, Res Inst Life Sci, Coll Vet Med, Jinju 52828, South Korea
[2] Korea Inst Toxicol, Gyeongnam Dept Environm Toxicol & Chem, Biol Resources Res Grp, Jinju 52834, South Korea
[3] Gyeongsang Natl Univ, Div Anim Biosci & Intergrated Biotechnol, Jinju 52725, South Korea
[4] Seoul Natl Univ, Res Inst Vet Sci, Coll Vet Med, BK21 PLUS Program Creat Vet Sci Res,Lab Dev Biol &, Seoul 08826, South Korea
[5] Kick Hurdle, R&D Grp, Changwon Si 51139, South Korea
关键词
probiotics; parabiotics; Lactobacilus sakei CVL-001; Lactobacilus casei MCL; atopic dermatitis (AD); anti-inflammation; CELLS; MICROBIOTA; FILAGGRIN; RISK; TH17;
D O I
10.3390/nu16172903
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
As it has been revealed that the activation of human immune cells through the activity of intestinal microorganisms such as pro- and prebiotics plays a vital role, controlling the proliferation of beneficial bacteria and suppressing harmful bacteria in the intestine has become essential. The importance of probiotics, especially for skin health and the immune system, has led to the emergence of products in various forms, including probiotics, prebiotics, and parabiotics. In particular, atopic dermatitis (AD) produces hypersensitive immunosuppressive substances by promoting the differentiation and activity of immune regulatory T cells. As a result, it has been in the Th1 and Th2 immune balance through a mechanism that suppresses skin inflammation or allergic immune responses caused by bacteria. Furthermore, an immune mechanism has recently emerged that simultaneously controls the expression of IL-17 produced by Th17. Therefore, the anti-atopic effect was investigated by administering doses of anti-atopic candidate substances (Lactobacilus sakei CVL-001, Lactobacilus casei MCL, and Lactobacilus sakei CVL-001 Lactobacilus casei MCL mixed at a ratio of 4:3) in an atopy model using 2,4-dinitrochlorobenzene and observing symptom changes for 2 weeks to confirm the effect of pro-, para-, and mixed biotics on AD. First, the body weight and feed intake of the experimental animals were investigated, and total IgG and IgM were confirmed through blood biochemical tests. Afterward, histopathological staining was performed using H&E staining, Toluidine blue staining, Filaggrin staining, and CD8 antibody staining. In the treatment group, the hyperproliferation of the epidermal layer, the inflammatory cell infiltration of the dermal layer, the expression of CD8, the expression of filaggrin, and the secretion of mast cells were confirmed to be significantly reduced. Lastly, small intestine villi were observed through a scanning microscope, and scoring evaluation was performed through skin damage. Through these results, it was confirmed that AD was reduced when treated with pro-, para-, and mixed biotics containing probiotics and parabiotics.<br />
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Epidermal loss of RORα accelerates skin inflammation in a mouse model of atopic dermatitis
    Hua, X.
    Dorsey, H.
    Hsung, R.
    Dai, J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (08) : S7 - S7
  • [2] IL-13 Regulation of Skin Remodeling in a Mouse Model of Atopic Dermatitis
    Zheng, T.
    Oh, M.
    Oh, S.
    Wit, F.
    Myers, A.
    Zhu, Z.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : S35 - S35
  • [3] The role of skin and intestinal microbiota in pathogenesis of atopic dermatitis and food allergy in mouse model
    Srutkova, D.
    Svabova, T.
    Zakostelska, Jiraskova Z.
    Thon, T.
    Makovicky, P.
    Schwarzer, M.
    Polouckova, A.
    Kopelentova, E.
    Tlaskalova-Hogenova, H.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2023, 53 : 87 - 87
  • [4] Blockade of OSMRβ signaling ameliorates skin lesions in a mouse model of human atopic dermatitis
    Komori, Tadasuke
    Hisaoka, Tomoko
    Kotaki, Ayumi
    Iwamoto, Miki
    Miyajima, Atsushi
    Esashi, Eiji
    Morikawa, Yoshihiro
    FASEB JOURNAL, 2024, 38 (01):
  • [5] The ACVD task force on canine atopic dermatitis (XVIII): histopathology of skin lesions
    Olivry, T
    Hill, PB
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2001, 81 (3-4) : 305 - 309
  • [6] An innovative preclinical mouse model of atopic dermatitis
    Bize, C.
    Fremez, C.
    De Pooter, A.
    Lecerf, G.
    Moga, A.
    Fontanie, M.
    Martin, P.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (12) : S215 - S215
  • [7] A humanized NOG mouse model for atopic dermatitis
    Poulsen, B. C.
    Dyring-Andersen, B.
    Skov, L.
    Aasted, B.
    Thestrup-Pedersen, K.
    Skak, K.
    Poulsen, L.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 : S1 - S1
  • [8] The NC/Nga mouse: a model for atopic dermatitis
    Vestergaard, C
    Yoneyama, H
    Matsushima, K
    MOLECULAR MEDICINE TODAY, 2000, 6 (05): : 209 - 210
  • [9] An Itchy Mouse: A Potential Model of Atopic Dermatitis
    Spock, Christopher
    Kirsner, Robert S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 (04) : 1064 - 1064
  • [10] The effect of probiotics on mouse model of atopic dermatitis
    Hsia, Y-P
    ALLERGY, 2013, 68 : 61 - 61